DiagnosTear Technologies Inc. (CSE:DTR)

Canada flag Canada · Delayed Price · Currency is CAD
0.290
-0.030 (-9.38%)
At close: Apr 28, 2026
16.00%
Market Cap 17.45M
Revenue n/a
Net Income n/a
Shares Out 60.19M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 750
Average Volume 14,619
Open 0.290
Previous Close 0.320
Day's Range 0.290 - 0.290
52-Week Range 0.200 - 0.880
Beta n/a
RSI 41.73
Earnings Date n/a

About DiagnosTear Technologies

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases. It develops TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform intended for the identification and monitoring of Dry Eye Syndrome (TeaR DES); TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a proprietary microfluidic tear collector that allows non-invasive collection of 1 microliter of tea... [Read more]

Industry Ophthalmic Goods
Founded 2023
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DTR
Full Company Profile

News

There is no news available yet.